LOINC Antibiotic susceptibility codes
Antibiotic susceptibility (ABXBACT): one class of the LOINC code system.
2,115 codes · page 37 of 43 · every class · by category · by group · panels · answer lists · parts
Hepatitis C virus genotype 3 NS5a gene mutations detected 82514-1 Velpatasvir (qualitative, genotype method) 82520-8 Paritaprevir (qualitative, genotype method) 82521-6 Simeprevir (qualitative, genotype method) 82522-4 Grazoprevir (qualitative, genotype method) 82523-2 Enfuvirtide (phenotype method) 82719-6 HIV 1 RNA genotype in Isolate 83325-1 HIV 1 RNA genotype and phenotype in Isolate 83326-9 HIV 1 RNA phenotype in Isolate 83327-7 ESBL (qualitative, cefepime to cefepime-clavulanate ic ratio by ard gradient strip) 85043-8 Staphylococcus aureus glycopeptide resistant based on vancomycin and teicoplanin IC (ard gradient strip) 85045-3 AmpC beta-lactamase (qualitative, cefotetan to cefotetan+cloxacillin inhibitory concentration ratio by ard gradient strip) 85046-1 MBL (qualitative, meropenem to meropenem-edta ic ratio by ard gradient strip) 85047-9 Micafungin (gradient strip) 85048-7 ESBL (qualitative, cefotaxime to cefotaxime-clavulanate ic ratio by ard gradient strip) 85049-5 ESBL (qualitative, ceftazidime to ceftazidime-clavulanate ic ratio by ard gradient strip) 85050-3 Telavancin (gradient strip) 85051-1 Ceftobiprole (gradient strip) 85052-9 MBL (qualitative, imipenem to imipenem-edta ic ratio by ard gradient strip) 85053-7 Isavuconazole (minimum inhibitory concentration (mic)) 85381-2 ceFAZolin for UTI (minimum inhibitory concentration (mic)) 85422-4 Eravacycline (minimum inhibitory concentration (mic)) 85423-2 Imipenem+Relebactam (minimum inhibitory concentration (mic)) 85424-0 Lefamulin (minimum inhibitory concentration (mic)) 85425-7 Meropenem for meningitis (minimum inhibitory concentration (mic)) 85426-5 Meropenem+Vaborbactam (minimum inhibitory concentration (mic)) 85427-3 Penicillin for meningitis (minimum inhibitory concentration (mic)) 85428-1 Penicillin for pneumonia (minimum inhibitory concentration (mic)) 85429-9 Carbapenem resistance blaIMP gene (qualitative, molecular method) 85498-4 Carbapenem resistance blaKPC gene (qualitative, naa with probe detection) 85499-2 Carbapenem resistance blaNDM gene (qualitative, naa with probe detection) 85500-7 Carbapenem resistance blaVIM gene (qualitative, molecular method) 85501-5 Carbapenem resistance blaOXA-48 gene (qualitative, molecular method) 85503-1 Methicillin resistance mecA gene (qualitative, naa with non-probe detection in positive blood culture) 85786-2 Vancomycin resistance vanA + vanB genes (qualitative, naa with non-probe detection in positive blood culture) 85787-0 Carbapenem resistance blaKPC gene (qualitative, naa with non-probe detection in positive blood culture) 85788-8 Beta-lactam resistance AmpC blaCMY+blaMOX genes (qualitative, molecular method) 85822-5 Carbapenem resistance blaGES gene (qualitative, molecular method) 85823-3 Carbapenem resistance blaIMP gene (qualitative, naa with probe detection) 85824-1 Carbapenem resistance blaOXA-23-like gene (qualitative, molecular method) 85825-8 Carbapenem resistance blaOXA-24-like gene (qualitative, molecular method) 85826-6 Carbapenem resistance bla OXA-48-like gene (qualitative, molecular method) 85827-4 Carbapenem resistance blaOXA-58-like gene (qualitative, molecular method) 85828-2 Carbapenem resistance blaSPM gene (qualitative, molecular method) 85829-0 Carbapenem resistance blaVIM gene (qualitative, naa with probe detection) 85830-8 Beta-lactam resistance ESBL blaBEL gene (qualitative, molecular method) 85831-6 Beta-lactam resistance ESBL blaCTX-M-1 Group gene (qualitative, molecular method) 85832-4 Carbapenem resistance blaGIM gene (qualitative, molecular method) 85833-2 Beta-lactam resistance ESBL blaCTX-M-9 Group gene (qualitative, molecular method) 85834-0 Beta-lactam resistance ESBL blaCTX-M-8+blaCTX-M-25 Group genes (qualitative, molecular method) 85835-7